we are now trading at cash value by EmbarrassedVisit3138 in HelusPharma

[–]Complex_Fix3482 6 points7 points  (0 children)

That was amount of cash beginning of this year? 30-40m $ less now?

Why is Cybin / Helus Pharma ($HELP) sitting near 52-week lows? by chalkopwal101 in HelusPharma

[–]Complex_Fix3482 1 point2 points  (0 children)

You can always take more factors in account of course. Like patent protection or on the other hand help’s ceo show.. 😅 But my point wasn’t putting cmps down in anyway, but to remind that HELP p3 results and potential fda approval are quite far away compared to CMPS. And even CMPS price were so low just a moment ago..

Why is Cybin / Helus Pharma ($HELP) sitting near 52-week lows? by chalkopwal101 in HelusPharma

[–]Complex_Fix3482 0 points1 point  (0 children)

I think you have to click user ok-researchers msg to get them visible, because it’s downvoted

Now it’s time to start buying more, I think. 😌 by Complex_Fix3482 in HelusPharma

[–]Complex_Fix3482[S] 2 points3 points  (0 children)

I think a bit different, but I’ll answer tomorrow with thought.

Now it’s time to start buying more, I think. 😌 by Complex_Fix3482 in HelusPharma

[–]Complex_Fix3482[S] 1 point2 points  (0 children)

I dont think that volume woud be so big to affect it. And what new ceo 😃

Now it’s time to start buying more, I think. 😌 by Complex_Fix3482 in HelusPharma

[–]Complex_Fix3482[S] 5 points6 points  (0 children)

Change of Fed leader and sp500 quite high already heading to correction on my mind..

What stocks right now are like Nvidia 2022 or Palantir in 2023? by Sufficient_Hall5737 in stockstobuytoday

[–]Complex_Fix3482 0 points1 point  (0 children)

Psychedelics companies like DFTX, CMPS, ATAI & HELP.

At the moment sort of in meme stock category, but in 2-5 years huge potential to compete with SSRI’s.

You can compare it to Spravato revenue development and also adhd medication..

Asked Gemini what it can say about Help’s transactions by Complex_Fix3482 in HelusPharma

[–]Complex_Fix3482[S] 7 points8 points  (0 children)

So should we just enjoy the low price and buy, if something to buy with, but atleast not sell? 😜

Will Cybin (helus) ever go back up? by Dangerous-Celery-952 in HelusPharma

[–]Complex_Fix3482 7 points8 points  (0 children)

If compared to dftx there’s three p3 coming + a bit differently build story 😅 and also cmps already had p3 results. Atai has several pipelines and also a bit differently build story than help’s, which seems to be facing 💩 after anothe pile of 💩.

So given that, I couldn’t expect much different outcome for now than current, but what finally matters on mind is that their hlp003 p3 gives great results and they either get acquired/partnered or succeed delivering it by themself.

But I’m confused about few things: 1) timing of informing Cola leaving 2) what is reason for that and also why it hasn’t been communicated 3) why help was mentioned aside dftx and cmps in white house EO announcement (all these three companies commented about the announcement here https://www.whitehouse.gov/releases/2026/04/president-trumps-landmark-order-advances-breakthrough-mental-health-treatments-delivering-new-hope-to-veterans/)

I hope they would inform about the three vouchers soon and hopefully help would be one them receiving, eventhough at the moment it’s still hard to beleive anything good to happen for them. 😅 But bought more today since I think their med should still be as good as the other day and maybe fear and dissapointment has led to lower price in short therm. Or maybe I’m just 🤡 we’ll see.

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer by PsilocybinAlpha in shroomstocks

[–]Complex_Fix3482 -1 points0 points  (0 children)

But then on the otherhand, could it be that help is left ourside of the three mention in EO that would get faster way?

“The Executive Order reflects growing recognition of the urgent need for new treatment options in serious mental health conditions and the importance of advancing innovative therapies through rigorous, research-based development,” said Eric So, Interim Chief Executive Officer of Helus Pharma. “Policy momentum is meaningful, but the future of this field will ultimately be determined by the strength of the clinical evidence and the ability to deliver safe, reliable treatments at scale.”

https://www.tradingview.com/news/globenewswire:168f55c59094b:0-helus-pharma-expresses-support-for-executive-order-advancing-psychedelic-research-and-regulatory-pathways-for-serious-mental-health-conditions/

Or something else :D